Platinum Group Metals Ltd. (NYSEMKT:PLG) reported an increase in the estimated inferred mineral resource at the Waterberg Joint Venture and adjacent Waterberg Extension to 29 million ounces of platinum, palladium, rhodium and gold. Platinum Group Metals Limited (USA) (NYSEMKT:PLG) weekly performance is 4.50%. On last trading day company shares ended up $1.16. Analysts mean target price for the company is $1.28. Platinum Group Metals Limited (USA) (NYSEMKT:PLG) distance from 50-day simple moving average (SMA50) is 9.19%.
Artisan Partners Asset Management (NASDAQ:APAM)’s stock had its “buy” rating restated by investment analysts at Citigroup Inc. in a note issued to investors on Tuesday. Artisan Partners Asset Management Inc. (NYSE:APAM) shares fell -0.94% in last trading session and ended the day on $54.65. APAM return on assets is -12.00%.Artisan Partners Asset Management Inc. (NYSE:APAM) quarterly performance is -12.12%.
Spansion Inc. (NYSE:CODE), a global leader in embedded systems, on 5 June announced a new family of power management integrated circuits (PMICs) for energy harvesting that can enable a greener Internet of Things (IoT) by eliminating the need for or extending the life of batteries in a multitude of IoT devices from individual wearable electronics to the nodes in wireless sensor networks. Spansion Inc. (NYSE:CODE) shares moved down -0.47% in last trading session and was closed at $21.38, while trading in range of $21.13 – $21.79. Spansion Inc. (NYSE:CODE) year to date (YTD) performance is 53.92%.
Raymond James reiterated their outperform rating on shares of Bancorp Inc. (NASDAQ:TBBK) in a research report sent to investors on Thursday morning. The firm currently has a $14.00 price target on the stock, down from their previous price target of $18.00. Bancorp Inc. (NASDAQ:TBBK) ended the last trading day at $11.37. Company weekly volatility is calculated as 7.52% and price to cash ratio as 0.53.Bancorp Inc. (NASDAQ:TBBK) showed a negative weekly performance of -30.33%.
Foundation Medicine, Inc. (NASDAQ:FMI) announced that members of the company’s management team will present at Steven J. Kafka, Ph.D., chief operating officer, will present at the JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 3:00 p.m. E.T. in New York, NY. Foundation Medicine Inc. (NASDAQ:FMI) weekly performance is -5.22%. On last trading day company shares ended up $22.86. Analysts mean target price for the company is $39.60. Foundation Medicine Inc. (NASDAQ:FMI) distance from 50-day simple moving average (SMA50) is -10.21%.